Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Delagrange

Showing results (31-40 of 98) with videos related to

Pageof 10
Sort By:
Physiology & Behavior|December 17, 1998
Effects of melatoninergic agonists on light-suppressed circadian rhythms in ratsK Witte, W Grebmer, E Scalbert, et al.
Brain Research Bulletin|April 1, 1991
Noradrenaline-like terminals in the cat nucleus ventralis posterior of the thalamusP Delagrange, M Conrath, M Geffard, et al.
Zhongguo Yao Li Xue Bao = Acta Pharmacologica Sinica|March 14, 2001
Effects of S-21007, a potent 5-HT3 partial agonist, in mouse anxietyP Delagrange, R Misslin, T W Seale, et al.
Journal of Neuroendocrinology|April 20, 2012
Neuroanatomical distribution of the orphan GPR50 receptor in adult sheep and rodent brainsM Batailler, A Mullier, A Sidibe, et al.
Pharmacology, Biochemistry, and Behavior|August 26, 1999
Effects of melatonin on neophobic responses in different strains of miceC Kopp, E Vogel, M C Rettori, et al.
Animal Reproduction Science|November 16, 2010
Functional characterization of polymorphic variants for ovine MT1 melatonin receptors: possible implication for seasonal reproduction in sheepE Trecherel, M Batailler, D Chesneau, et al.
Brain Research|June 3, 1999
A single oral dose of S 22153, a melatonin antagonist, blocks the phase advancing effects of melatonin in C3H miceL Weibel, M C Rettori, D Lesieur, et al.
British Journal of Pharmacology|August 24, 1999
Effects of melatonin on rat pial arteriolar diameter in vivoO Régrigny, P Delagrange, E Scalbert, et al.
European Journal of Pharmacology|January 18, 1996
Melatonin analogues as agonists and antagonists in the circadian system and other brain areasS W Ying, B Rusak, P Delagrange, et al.
Biochemical Pharmacology|May 2, 2001
Comparative pharmacological studies of melatonin receptors: MT1, MT2 and MT3/QR2. Tissue distribution of MT3/QR2 O Nosjean, J P Nicolas, F Klupsch, et al.
Pageof 10

Showing results (31-40 of 98) with videos related to

Sort By:
Pageof 10
Physiology & Behavior|December 17, 1998
Effects of melatoninergic agonists on light-suppressed circadian rhythms in ratsK Witte, W Grebmer, E Scalbert, et al.
Brain Research Bulletin|April 1, 1991
Noradrenaline-like terminals in the cat nucleus ventralis posterior of the thalamusP Delagrange, M Conrath, M Geffard, et al.
Zhongguo Yao Li Xue Bao = Acta Pharmacologica Sinica|March 14, 2001
Effects of S-21007, a potent 5-HT3 partial agonist, in mouse anxietyP Delagrange, R Misslin, T W Seale, et al.
Journal of Neuroendocrinology|April 20, 2012
Neuroanatomical distribution of the orphan GPR50 receptor in adult sheep and rodent brainsM Batailler, A Mullier, A Sidibe, et al.
Pharmacology, Biochemistry, and Behavior|August 26, 1999
Effects of melatonin on neophobic responses in different strains of miceC Kopp, E Vogel, M C Rettori, et al.
Animal Reproduction Science|November 16, 2010
Functional characterization of polymorphic variants for ovine MT1 melatonin receptors: possible implication for seasonal reproduction in sheepE Trecherel, M Batailler, D Chesneau, et al.
Brain Research|June 3, 1999
A single oral dose of S 22153, a melatonin antagonist, blocks the phase advancing effects of melatonin in C3H miceL Weibel, M C Rettori, D Lesieur, et al.
British Journal of Pharmacology|August 24, 1999
Effects of melatonin on rat pial arteriolar diameter in vivoO Régrigny, P Delagrange, E Scalbert, et al.
European Journal of Pharmacology|January 18, 1996
Melatonin analogues as agonists and antagonists in the circadian system and other brain areasS W Ying, B Rusak, P Delagrange, et al.
Biochemical Pharmacology|May 2, 2001
Comparative pharmacological studies of melatonin receptors: MT1, MT2 and MT3/QR2. Tissue distribution of MT3/QR2 O Nosjean, J P Nicolas, F Klupsch, et al.
Pageof 10